Skip to content
EntityQ4770927· pop 5· linked from 10 articles

antalarmin

Sign in to save

Antalarmin (CP-156,181) is a drug that acts as a CRH1 antagonist.

~11 min read

Encyclopedic overview

11 sections
Contents
  • Chemical structure
  • Mechanism of action
  • Receptor binding
  • Pharmacokinetics (ADME)
  • ''In vitro'' and ''in vivo'' research
  • Stress and anxiety
  • Neurodegeneration
  • Inflammation
  • Addiction
  • See also
  • References

Antalarmin (CP-156,181) is a drug that acts as a CRH1 antagonist.

Corticotropin-releasing hormone (CRH), also known as Corticotropin-releasing factor, is an endogenous peptide hormone released in response to various triggers such as chronic stress and drug addiction. Such triggers result in the release of corticotropin (ACTH), another hormone involved in the physiological response to stress. Chronic release of CRH and ACTH is believed to be directly or indirectly involved in many of the harmful physiological effects of chronic stress, such as excessive glucocorticoid release, stomach ulcers, anxiety, diabetes mellitus, osteoporosis, depression, and development of high blood pressure and consequent cardiovascular problems.

Excerpted from Wikipedia’s “antalarmin” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0